L'intérêt à découvert pour Co-Diagnostics donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Co-Diagnostics. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Co-Diagnostics (NASDAQ:CODX) Stock, Rapport sur les intérêts à découvert

CO-DIAGNOSTICS INC

Co-Diagnostics

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Co-Diagnostics Inc

<ul>
<li>New data reveal a 78% reduction in cardiovascular disease-related hospitalizations for people living with Type 1 diabetes with prior severe low blood sugar episodes.1</li>
<li>This significant decrease is linked to the use of Libre biowearable technology compared to traditional blood glucose monitors.1</li>
<li>Results also show a reduction in hospitalization for cardiovascular complications in adults with Type 2 diabetes on insulin using Libre technology.2</li>
</ul>

Biotech

News

General

Abbott Laboratories Announces REFLECT Real-World Studies Results That Shows Use Of FreeStyle Libre Continuous Glucose Monitoring Technology Associated With Significant Reduction In Risk Of Hospitalization For Heart Complications In People With Diabetes.

Ethereum's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) powerful rally is reviving optimism across the altcoin space, with top analysts projecting a full-scale <a href="https://www.benzinga.com/markets/25/05/45384345/top-altcoins-of-the-week-altcoin-market-pops-as-eth-pi-and-pepe-post-double-digit-gains">altcoin bull market in 2025.</a>
What Happened: During an <a href="https://www.youtube.com/live/awSZ1sMk7PI">episode</a> of the Wolf of All Streets podcast with Scott Melker published on May 14, Matthew Sigel, Head of Digital Assets Research at VanEck, said Ethereum's 44% weekly surge has flipped sentiment across the sector.
We're seeing the beginning of an "altcoin bull market," Sigel said, pointing to Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) already outperforming Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>).
He attributes the ETH rally to multiple catalysts, including the Dencun upgrade, leadership shifts within the Ethereum Foundation, and an aggressive short squeeze, particularly from institutions that had been short ETH against long BTC and SOL positions.
Sigel added that while short-term headwinds like dollar strength may slow momentum, the structural setup remains bullish. Bernstein Research echoed this view, citing Layer 2 adoption, growing stablecoin and tokenization activity and renewed institutional flows.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45406271/ethereum-rallies-42-in-7-days-what-is-driving-the-surge">Ethereum Rallies 42% In 7 Days: What Is Driving The Surge?</a>
Why It Matters: Sigel's remarks coincided with the launch of VanEck's Onchain Economy ETF (NØDE), a hybrid fund combining crypto ETF exposure (25%) with high- and low-volatility blockchain equities. 
VanEck also rolled out a tokenized U.S. Treasury fund, accessible via Ethereum, Solana, Avalanche (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/avax/usd">AVAX</a>), and BNB Chain, a move targeting institutional clients seeking 24/7 access and USDC-based settlement.
Meanwhile, Matt Hougan, Chief Investment Officer at BitwiseInvest, <a href="https://x.com/Matt_Hougan/status/1922704807204471245">highlighted</a> the growing embrace of crypto among financial advisors after attending a major industry conference. 
He shared three key insights: crypto ETP access is expected across most advisory firms by year-end, advisor demand is intensifying, with billions in expected inflows and portfolio allocations rising from 1% to 5%.
"I fielded more Ethereum questions in the past few days than in the last six months," Hougan noted, emphasizing that interest is surging for both Bitcoin and Ethereum.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45403187/bernstein-identifies-three-key-drivers-behind-ethereums-recent-rally">3 Key Drivers Behind Ethereum&#8217;s 65% Rally: Bernstein</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$AVAX

$BTC

$DOGE

$ETH

$SOL

Ethereum's Surge Could Kick Off The 2025 'Altcoin Bull Market', Experts Say

President Dave Rosa promoted to CEO Current CEO Gary Guthart to become executive chair of Intuitive's board Current Board Chair Craig Barratt to become lead independent director
SUNNYVALE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of President Dave Rosa to chief executive officer, effective July 1, 2025. At that time, current CEO Gary Guthart will become the executive chair of Intuitive's board of directors, and current Board Chair Craig Barratt will become lead independent director. Guthart will work closely with Rosa to support a smooth transition and will remain with Intuitive in a senior advisory capacity.

Management

ISRG

Intuitive Promotes President Dave Rosa To CEO, Effective July 1, 2025

Aclarion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) reported quarterly losses of $(9.32) per share which beat the analyst consensus estimate of $(1.45 thousand) by 99.36 percent. This is a 99.79 percent increase over losses of $(4.40 thousand) per share from the same period last year. The company reported quarterly sales of $18.99 thousand which missed the analyst consensus estimate of $30.00 thousand by 36.70 percent. This is a 87.77 percent increase over sales of $10.11 thousand the same period last year.

Earnings

Earnings Beats

Earnings Misses

ACON

Aclarion Q1 EPS $(9.32) Beats $(1.45K) Estimate, Sales $18.99K Miss $30.00K Estimate

Cloudastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSAI#NASDAQ">CSAI</a>) reported $738.00 thousand in sales this quarter. This is a 211.39 percent increase over sales of $237.00 thousand the same period last year.

CSAI

Cloudastructure Q1 EPS $(0.00017) Vs $(0.00012) YoY, Sales $738.00K Up From $237.00K YoY

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">79.70</td>
<td align="right">0.19</td>
<td align="right">0.23</td>
<td>3.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">79.39</td>
<td align="right">0.09</td>
<td align="right">0.11</td>
<td>5.9K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">84.47</td>
<td align="right">-0.78</td>
<td align="right">-0.92</td>
<td>153.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">215.00</td>
<td align="right">-1.11</td>
<td align="right">-0.52</td>
<td>7.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">233.00</td>
<td align="right">-1.13</td>
<td align="right">-0.49</td>
<td>66.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">40.61</td>
<td align="right">-0.13</td>
<td align="right">-0.32</td>
<td>210</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">140.28</td>
<td align="right">-0.32</td>
<td align="right">-0.23</td>
<td>4.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">50.83</td>
<td align="right">-0.11</td>
<td align="right">-0.22</td>
<td>170.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">128.70</td>
<td align="right">-0.07</td>
<td align="right">-0.06</td>
<td>19.2K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> the above sector movers alert assists traders in understanding macro-level trends and market variations. Traders will look for sector movers providing information on sectors that are over- or under-performing, deriving these results into investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

Movers

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For May 15, 2025

Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) announced today that its subsidiary, Phillips 66 Continental Holding GmbH, has entered into a definitive agreement to divest a 65 percent interest in its Germany and Austria retail marketing business, including JET-branded sites, to a consortium owned by subsidiaries of investment firms Energy Equation Partners and Stonepeak. Phillips 66 will retain a non-operated 35 percent interest in the business through a newly formed joint venture.
The transaction values the Germany and Austria retail marketing business at an enterprise value of approximately €2.5 billion (approximately $2.8 billion), representing an implied Enterprise Value/EBITDA multiple of 9.1x based on expected 2025 EBITDA. Phillips 66 expects to receive pre-tax cash proceeds of approximately €1.5 billion (approximately $1.6 billion), after customary purchase price adjustments. The proceeds will be used to support the company's strategic priorities, including debt reduction and shareholder returns.
In connection with the transaction, Phillips 66 will enter into a multi-year agreement to continue to supply the business with products from the Mineraloelraffinerie Oberrhein GmbH &amp; Co. KG (MiRO) Refinery.
The Germany and Austria retail business includes 970 sites, of which 843 are JET-branded sites. The transaction is expected to close in the second half of 2025, subject to regulatory approvals and other customary conditions.

Phillips 66 Continental Holding Agrees To Divest 65% Interest In Germany And Austria Retail Marketing Business In $2.8B Deal

MKS Instruments, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) ("MKS"), a global provider of enabling technologies that transform our world, announced today that James A. Schreiner will conclude his tenure as the leader of the Materials Solutions Division ("MSD") on August 1, 2025, and will transition back to his role as Executive Vice President &amp; Chief Operating Officer of MKS. In this position, Mr. Schreiner will lead operations, supply chain, and workplace operations for the Vacuum Solutions Division and the Photonics Solutions Division.
The Company also announced that David P. Henry, the Company's current Executive Vice President, Operations and Corporate Marketing, will assume the role of Executive Vice President, Global Strategic Marketing, and General Manager, Materials Solutions Division, on August 1, 2025. In this role, Mr. Henry will succeed Mr. Schreiner as the leader of MSD as well as maintain responsibility for strategic and corporate marketing for the Company.

MKSI

MKS Instruments Announces Leadership Transition As James A. Schreiner To Step Down From Materials Solutions Division On August 1, 2025 And Will Transition Back To His Role As Executive Vice President & COO

Bonterra Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BNE#TSX">BNE</a>) reported quarterly losses of $(0.20) per share. This is a 1100 percent decrease over earnings of $0.02 per share from the same period last year. The company reported $70.69 million in sales this quarter. This is a 3.06 percent increase over sales of $68.59 million the same period last year.

TSX:BNE

Bonterra Energy Q1 EPS $(0.20) Down From $0.02 YoY, Sales $70.69M Up From $68.59M YoY

On Thursday, retail giant&nbsp;Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) reported&nbsp;first-quarter&nbsp;FY26 sales growth of&nbsp;2.5%&nbsp;year-on-year (Y/Y) to&nbsp;$165.60&nbsp;billion, marginally missing the analyst&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45432296/walmart-reports-revenue-of-2-5-up-4-0-in-constant-currency-cc-with-operating-income-growing-of-4-3" rel="noreferrer noopener">consensus estimate of&nbsp;$165.88 billion</a>.
The retailer reported adjusted EPS&nbsp;of 61 cents,&nbsp;<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beating the consensus estimate of 58 cents.</a>
Global eCommerce sales grew&nbsp;22% Y/Y, led by store-fulfilled pickup &amp; delivery and marketplace.
Comparable sales for Walmart U.S. climbed by&nbsp;4.5%, excluding fuel, driven by health &amp; wellness and grocery growth. At Sam's Club, same-store sales rose&nbsp;6.7% Y/Y, excluding fuel.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45422271/walmart-faces-tariff-test-this-quarter-preview" rel="noreferrer noopener">Walmart Q1 Earnings Preview: Why Retailer Will Have ‘One Of The Most Telling' Reports On Tariff Impact</a>
The gross margin rate was up 12&nbsp;basis points, led by Walmart U.S.
Operating income increased&nbsp;$0.3 billion, or&nbsp;4.3%, and adjusted operating&nbsp;income&nbsp;was up&nbsp;3.0%&nbsp;in constant currencies due to higher gross margins and growth in membership income.
Global advertising business improved&nbsp;50% Y/Y, including&nbsp;31% Y/Y&nbsp;for Walmart Connect in the U.S.
"We delivered a solid first quarter in a dynamic operating environment. We're serving customers and members in more ways, which is fueling our growth. We're well positioned, maintaining flexibility to navigate the near-term while continuing to invest to create value for the long-term." said President and CEO&nbsp;Doug McMillon.
Walmart generated an operating cash flow of&nbsp;$5.4 billion&nbsp;and a free cash flow of&nbsp;$425 million&nbsp;in the quarter. It ended the quarter with cash and equivalents of&nbsp;$9.3 billion.
<h2 class="wp-block-heading">Guidance</h2>
Walmart expects&nbsp;second-quarter&nbsp;FY26 <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">sales growth of&nbsp;3.5%—4.5%&nbsp;in CC</a>, translating to $173.67 billion—$175.35 billion versus the $175.21 billion estimate.
For fiscal year 2026, Walmart reaffirmed an adjusted EPS outlook of&nbsp;$2.50&nbsp;–&nbsp;$2.60, vs. the&nbsp;$2.61 estimate and sales&nbsp;guidance&nbsp;of&nbsp;$694.70 billion—$701.50 billion vs. the&nbsp;street view of $705.30 billion.
<h2 class="wp-block-heading">Conference Call</h2>
During the conference call, CEO reportedly says, "all of the tariffs create cost pressure for us, but the larger tariffs on china have the biggest impact for us; ‘we won't let tariff-related cost pressure on some general merchandise items put pressure on food prices; but as it relates to food area for imported items like bananas, avocados, coffee and roses, will do our best to control."
The CFO reportedly said, "February was softer than expected, March was back to normal, and April was very strong; we will need to manage quantity volumes as we measure tariffs."
Investors can gain exposure to the stock via Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSTA#NYSE">FSTA</a>) and Vanguard Consumer Staples ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VDC#NYSE">VDC</a>).
Price Action:&nbsp;WMT shares are down 0.71% to $96.14 premarket at the last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/large-cap/25/05/45357178/walmart-analysts-strategy-curbs-price-hikes-despite-tariffs" target="_blank" rel="noreferrer noopener">Walmart Analysts: Strategy Curbs Price Hikes Despite Tariffs</a></li>
</ul>
Image via Shutterstock

Large Cap

Guidance

FSTA

Walmart Doesn't Alter Annual Outlook Yet, CEO Says 'All Tariffs Create Cost Pressures But China Has Biggest Impact'

Loop Capital analyst Chris Dankert maintains Rockwell Automation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) with a Hold and raises the price target from $280 to $290.

Price Target

Analyst Ratings

Loop Capital Maintains Hold on Rockwell Automation, Raises Price Target to $290

WIIM

WMT stock has given up its prior gain. Walmart shares were trading higher following Q1 financial results.

Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) chief Marc Benioff says Silicon Valley's frenetic rush to bankroll thousands of AI start-ups isn't a bubble worth fearing but the price of true breakthroughs.
What Happened: "If you don't have all those components, you're not going to get the breakthrough … you're going to have to throw a lot against the wall before you figure out what sticks," he told the Financial Times in a new <a href="https://www.ft.com/content/c4efe4d3-15d7-44b6-b93f-497f1368ce48">interview</a>, adding that "these 10,000 companies just got funded, and only 100 of them are good. But you have to fund them all to get to the 100."
Benioff argues the same spray-and-pray logic propelled past revolutions from the browser to the iPhone, and he's applying it inside Salesforce with an "all-in" push on <a href="https://www.benzinga.com/markets/equities/24/09/40745835/salesforce-ceo-marc-benioff-pivots-strategy-to-autonomous-ai-agents-after-venture-capital-firm-s">autonomous AI agents</a>.
The company's Agentforce platform, unveiled last year, aims to seed a "<a href="https://www.benzinga.com/news/management/24/11/41978942/salesforce-ceo-marc-benioff-bets-big-on-billion-bots">billion bots</a>" that can handle routine tasks for clients, a goal he reiterated while <a href="https://www.benzinga.com/news/24/09/40954193/salesforce-ceo-marc-benioff-slams-microsofts-copilot-compares-it-to-failed-clippy-assistant-like-wer">blasting</a> rival Microsoft's Copilot as "science projects."
See also: <a href="https://www.benzinga.com/25/05/45435279/warren-buffetts-net-worth-secret-is-tied-to-the-luckiest-day-of-his-life-if-i-were-being-born-today-i-would-just-keep-negotiating-in-the-womb-until">Warren Buffett&#8217;s Net Worth Secret Is Tied To The &#8216;Luckiest Day&#8217; Of His Life: &#8216;If I Were Being Born Today, I Would Just Keep Negotiating In The Womb Until&#8230;&#8217;</a>
Why It Matters: The 60-year-old billionaire has plenty of personal capital riding on the thesis. Salesforce Ventures has $6.8 billion under management and just scored a roughly $600 million gain when Google bought cybersecurity firm Wiz, one of hundreds of bets Benioff calls his "side hustle" in an <a href="https://www.businessinsider.com/marc-benioff-salesforce-ventures-investing-startups-silicon-valley-2025-5">interview</a> with Business Insider.
Time Ventures and the company's $1 billion Generative AI Fund have <a href="https://www.benzinga.com/news/24/09/40841369/ai-powered-agentforce-and-dreamforce-highlight-salesforces-next-revenue-surge-goldman-sachs-analyst">already poured cash</a> into Anthropic and other up-and-comers chasing the next platform shift.
Benioff's willingness to bankroll long shots dates back to his mentor Steve Jobs and, more recently, to Salesforce's own leap from CRM software to multitrillion-dollar "<a href="https://www.benzinga.com/25/02/43999577/salesforce-aims-beyond-crm-bets-big-on-digital-labor-revolution-as-ceo-predicts-up-to-12-trillion-market">digital labor</a>," a market he says will dwarf every tech wave before it.
"You must fund the chaos to harvest the miracles," he said to FT, insisting the current hype cycle is a feature, not a bug, of innovation.
Read next: <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45435725/tariffs-slow-retail-spending-as-producer-prices-post-sharpest-drop-since-2020">Tariffs Slow Retail Spending As Producer Prices Post Sharpest Drop Since 2020</a>

Startups

Salesforce CEO Marc Benioff Says Funding Thousands Of Startups Is How Innovation Happens: 'You're Going To Throw A Lot Against The Wall'

Connect Biopharma Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTB#NASDAQ">CNTB</a>) reported quarterly losses of $(0.19) per share. This is a 18.75 percent decrease over losses of $(0.16) per share from the same period last year.

CNTB

Connect Biopharma Hldgs Q1 EPS $(0.19) Down From $(0.16) YoY

Statistically significant safety and efficacy data from 0.25 mg and 0.50 mg cohorts to be presented
Presentation scheduled for Thursday, May 15, 2025, at 11:36 a.m. PT
PITTSBURGH, May 15, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIPO#NASDAQ">LIPO</a>) ("Lipella," "we," "our," or the "Company"), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet needs, today announced that topline data from the first two dose cohorts of its ongoing Phase 2a trial of LP-310 (liposomal tacrolimus oral rinse) for the treatment of Oral Lichen Planus (OLP) will be presented at the 2025 joint international meeting of the American Academy of Oral Medicine (AAOM) and the European Association of Oral Medicine (EAOM) in Las Vegas.

LIPO

Lipella Pharma To Present Topline Data From First Two Dose Cohorts Of Ongoing Phase 2A Trial Of LP-310 For Treatment Of OLP At 2025 Joint International Meeting Of AAOM And EAOM In Las Vegas

BEKE

KE Holdings shares are trading lower. The company reported Q1 financial results.

Verde AgriTech (TSX:<a class="ticker" href="https://www.benzinga.com/stock/NPK#TSX">NPK</a>) reported quarterly losses of $(0.07) per share. This is a 22.22 percent increase over losses of $(0.09) per share from the same period last year. The company reported $2.85 million in sales this quarter. This is a 43.73 percent decrease over sales of $5.07 million the same period last year.

TSX:NPK

Verde AgriTech Q1 EPS $(0.07) Up From $(0.09) YoY, Sales $2.85M Down From $5.07M YoY

CEL-SCI (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVM#AMEX">CVM</a>) reported quarterly losses of $(0.08) per share. This is a 42.86 percent increase over losses of $(0.14) per share from the same period last year.

Comments

Co-Diagnostics

Intérêt court

Co-Diagnostics (NASDAQ:CODX) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL